title: Phenotypic and genomic analysis of serotype 3 Sabin poliovirus vaccine produced in MRC-5 cell substrate.
abstract: The cell substrate has a pivotal role in live virus vaccines production. It is necessary to evaluate the effects of the cell substrate on the properties of the propagated viruses, especially in the case of viruses which are unstable genetically such as polioviruses, by monitoring the molecular and phenotypical characteristics of harvested viruses. To investigate the presence/absence of mutation(s), the near full-length genomic sequence of different harvests of the type 3 Sabin strain of poliovirus propagated in MRC-5 cells were determined. The sequences were compared with genomic sequences of different virus seeds, vaccines, and OPV-like isolates. Nearly complete genomic sequencing results, however, revealed no detectable mutations throughout the genome RNA-plaque purified (RSO)-derived monopool of type 3 OPVs manufactured in MRC-5. Thirty-six years of experience in OPV production, trend analysis, and vaccine surveillance also suggest that: (i) different monopools of serotype 3 OPV produced in MRC-5 retained their phenotypic characteristics (temperature sensitivity and neuroattenuation), (ii) MRC-5 cells support the production of acceptable virus yields, (iii) OPV replicated in the MRC-5 cell substrate is a highly efficient and safe vaccine. These results confirm previous reports that MRC-5 is a desirable cell substrate for the production of OPV.
authors.affiliation: Human Viral Vaccines Research and Production Department, Razi Vaccine and Serum Research Institute, Karaj, Tehran, Iran. b.alirezaie@rvsri.ir
authors.forename: Behnam
authors.initials: B
authors.lastname: Alirezaie
authors.forename: Mohammad
authors.initials: M
authors.lastname: Taqavian
authors.forename: Khosrow
authors.initials: K
authors.lastname: Aghaiypour
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Esna-Ashari
authors.forename: Abbas
authors.initials: A
authors.lastname: Shafyi
mesh_terms: D018929:Cell Culture Techniques; D002460:Cell Line; D016679:Genome, Viral; D042822:Genomic Instability; D006801:Humans; D009154:Mutation; D017955:Poliovirus / Q000235:genetics* / Q000254:growth & development* / Q000302:isolation & purification; D023321:Poliovirus Vaccines / Q000235:genetics* / Q000302:isolation & purification*; D012367:RNA, Viral / Q000235:genetics; D017422:Sequence Analysis, DNA
chemical_list: D023321:Poliovirus Vaccines; D012367:RNA, Viral